The RESPOND Registry

CompletedOBSERVATIONAL
Enrollment

310

Participants

Timeline

Start Date

February 21, 2017

Primary Completion Date

July 15, 2018

Study Completion Date

January 26, 2019

Conditions
Partial Thickness WoundPressure UlcerVenous UlcerDiabetic UlcerSurgical WoundsTrauma WoundsDraining WoundsChronic Vascular Ulcer
Interventions
DEVICE

PuraPly™ Antimicrobial Wound Matrix

PuraPly™ Antimicrobial Wound Matrix consists of a collagen sheet coated with 0.1% polyhexamethylenebiguanide hydrochloride (PHMB) intended for the management of wounds.

Trial Locations (15)

11968

Southampton Hospital, Southampton

17112

Harrisburg Foot and Ankle Center, Inc., Harrisburg

18104

Sacred Heart Hospital, Allentown

27534

Wayne Memorial Hospital, Goldsboro

29605

Greensville Health System, Greenville

33155

West Gables Rehab Hospital, Miami

33458

Jupiter Medical Center, Jupiter

53713

Meriter Hospital Inc., DBA: UnityPoint Health Heart and Vascular Institute, Madison

63128

Saint Louis Foot and Ankle, St Louis

70403

Wound Care Associates, LLC., Hammond

70433

Institute for Advanced Wound Healing; Northshore Specialty Hospital, Covington

70570

Opelousas General Hospital Wound Center, Opelousas

86314

Advanced Wound Care Center at Yavapai Regional Medical Center, Prescott Valley

07728

CentraState Medical Center, Freehold

08690

Robert Wood Johnson Hamilton, Hamilton

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Continuum Clinical Inc.

UNKNOWN

lead

Organogenesis

INDUSTRY

NCT03286452 - The RESPOND Registry | Biotech Hunter | Biotech Hunter